Melasma Clinical Trials 2023

Melasma Clinical Trials 2023

Melasma research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in melasma clinical trials today.

Melasma Clinical Trials

Here are the 0 most popular medical studies for melasma

Popular filter options for melasma trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to melasma

What are the top hospitals conducting melasma research?

Melasma, a common skin condition characterized by dark patches on the face, is being actively studied and treated at some of the top hospitals across the United States. In Sacramento, Integrative Skin and Research is leading the way with their dedicated research efforts in melasma. Although they currently have one active trial and only one recorded trial to date since 2023, their commitment to finding effective treatments for this condition is commendable. On the East Coast, UnionDerm in New York City joins the pursuit with one ongoing melasma trial that builds upon their first recorded study in 2022. Meanwhile, at Laser & Skin Surgery Center of New York, researchers are also focusing on melasma with an active trial underway as part of their extensive work in this field since 2018.

Not far behind, Dermatology & Laser Surgery Center based out of Houston has embarked on its own investigations into melasma starting from 2018. With one current clinical trial ongoing alongside past endeavors; both showing dedication towards bringing relief for those affected by this pigmentation disorder.In another center sharing a similar name - Laser and Skin Surgery Center of New York - additional progress has been made over time through two completed trials conducted so far; it all began backin2017.

These hospitals' unwavering focus on studying melasma shows promise for individuals seeking solutions to manage or alleviate this challenging skin condition.Though these institutions may seem few right now when it comes to number but each new study brings us closer to better understanding and potential breakthroughs that could potentially transform lives impacted by melasmas worldwide

Which are the best cities for melasma clinical trials?

When it comes to melasma clinical trials, several cities offer opportunities for participation. New York, New York leads the way with 3 active studies exploring treatments like Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine and the LaseMD System. Other cities such as Sacramento, California. New York, New York leads the way with 3 active studies exploring treatments like Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine and the LaseMD System. Other cities such as Sacramento, California; Houston, Texas; Chicago, Illinois; and Mitchellville, Maryland also have ongoing trials investigating various interventions for melasma including acne vulgaris and glycolic acid peels. These cities provide individuals affected by melasma with access to cutting-edge research that may lead to improved treatment options in the future.

Which are the top treatments for melasma being explored in clinical trials?

Melasma, a common skin condition that causes dark patches on the face, is currently undergoing clinical trials to explore potential treatments. Among the top contenders are:

  • LaseMD System: A promising treatment option with one active trial and one all-time melasma trial since its introduction in 2018.
  • Glycolic Acid Peels: Another contender showing potential, with one ongoing trial and two all-time melasma trials documented since 2013.

These treatments offer hope for individuals affected by melasma as researchers continue to investigate their effectiveness in combating this challenging condition.

What are the most recent clinical trials for melasma?

Recent clinical trials have focused on finding effective treatments for melasma, a common skin condition characterized by hyperpigmentation. One promising avenue is the exploration of various treatment options in Phase 4 trials. These studies aim to evaluate the efficacy and safety of different interventions specifically designed for melasma. Among these interventions is azelaic acid, which has shown potential in reducing melasma-related pigmentation. With ongoing research efforts dedicated to understanding and addressing this condition, individuals affected by melasma can look forward to advancements that may offer them improved management strategies.

What melasma clinical trials were recently completed?

A number of recent clinical trials have examined potential treatments for melasma, a skin condition characterized by dark patches on the face. These trials aim to find effective remedies and provide hope for individuals affected by this challenging condition. While various studies have been conducted, three noteworthy completed trials include investigations into novel therapies such as topical creams containing tranexamic acid or arbutin, laser treatments using low-fluence Q-switched Nd:YAG lasers, and oral administration of polypodium leucotomos extract capsules. The outcomes of these trials offer valuable insights into the management and treatment of melasma, bringing us closer to finding solutions that can improve the lives of those living with this condition.